Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition

被引：44
作者：
Raab, Marc S. [1 ,2 ]
Lehners, Nicola [1 ,2 ]
Xu, Jing [1 ,2 ]
Ho, Anthony D. [1 ]
Schirmacher, Peter [3 ]
Goldschmidt, Hartmut [1 ,4 ]
Andrulis, Mindaugas [3 ]
机构：
[1] Univ Heidelberg Hosp, Dept Med 5, INF410, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany
[4] Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
BLOOD | 2016年 / 127卷 / 17期
关键词：
HETEROGENEITY;
D O I：
10.1182/blood-2015-12-686782
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2155 / 2157
页数：3
相关论文
共 6 条
  • [1] Targeting the BRAF V600E Mutation in Multiple Myeloma
    Andrulis, Mindaugas
    Lehners, Nicola
    Capper, David
    Penzel, Roland
    Heining, Christoph
    Huellein, Jennifer
    Zenz, Thorsten
    von Deimling, Andreas
    Schirmacher, Peter
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Neben, Kai
    Raab, Marc S.
    [J]. CANCER DISCOVERY, 2013, 3 (08) : 862 - 869
  • [2] Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
    Bolli, Niccolo
    Avet-Loiseau, Herve
    Wedge, David C.
    Van Loo, Peter
    Alexandrov, Ludmil B.
    Martincorena, Inigo
    Dawson, Kevin J.
    Iorio, Francesco
    Nik-Zainal, Serena
    Bignell, Graham R.
    Hinton, Jonathan W.
    Li, Yilong
    Tubio, Jose M. C.
    McLaren, Stuart
    Meara, Sarah O'
    Butler, Adam P.
    Teague, Jon W.
    Mudie, Laura
    Anderson, Elizabeth
    Rashid, Naim
    Tai, Yu-Tzu
    Shammas, Masood A.
    Sperling, Adam S.
    Fulciniti, Mariateresa
    Richardson, Paul G.
    Parmigiani, Giovanni
    Magrangeas, Florence
    Minvielle, Stephane
    Moreau, Philippe
    Attal, Michel
    Facon, Thierry
    Futreal, P. Andrew
    Anderson, Kenneth C.
    Campbell, Peter J.
    Munshi, Nikhil C.
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [3] Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
    Das Thakur, Meghna
    Salangsang, Fernando
    Landman, Allison S.
    Sellers, William R.
    Pryer, Nancy K.
    Levesque, Mitchell P.
    Dummer, Reinhard
    McMahon, Martin
    Stuart, Darrin D.
    [J]. NATURE, 2013, 494 (7436) : 251 - 255
  • [4] NF-κB as a therapeutic target in multiple myeloma
    Hideshima, T
    Chauhan, D
    Richardson, P
    Mitsiades, C
    Mitsiades, N
    Hayashi, T
    Munshi, N
    Dang, L
    Castro, A
    Palombella, V
    Adams, J
    Anderson, KC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) : 16639 - 16647
  • [5] Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
    Lohr, Jens G.
    Stojanov, Petar
    Carter, Scott L.
    Cruz-Gordillo, Peter
    Lawrence, Michael S.
    Auclair, Daniel
    Sougnez, Carrie
    Knoechel, Birgit
    Gould, Joshua
    Saksena, Gordon
    Cibulskis, Kristian
    McKenna, Aaron
    Chapman, Michael A.
    Straussman, Ravid
    Levy, Joan
    Perkins, Louise M.
    Keats, Jonathan J.
    Schumacher, Steven E.
    Rosenberg, Mara
    Getz, Gad
    Golub, Todd R.
    [J]. CANCER CELL, 2014, 25 (01) : 91 - 101
  • [6] Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma
    Walker, Brian A.
    Wardell, Christopher P.
    Melchor, Lorenzo
    Hulkki, Sanna
    Potter, Nicola E.
    Johnson, David C.
    Fenwick, Kerry
    Kozarewa, Iwanka
    Gonzalez, David
    Lord, Christopher J.
    Ashworth, Alan
    Davies, Faith E.
    Morgan, Gareth J.
    [J]. BLOOD, 2012, 120 (05) : 1077 - 1086
1